Hints and tips:
...Additional reporting by Wang Xueqiao in Shanghai...
...Xuefeng, deputy-director of the Hebei People’s Congress....
...Yu Xuefeng, co-founder, chair and chief executive of CanSino, told the Financial Times that it was developing a “bivalent vaccine against Omicron, which has entered the late stage clinical trials”....
International Edition